Recently, JHL Biotech co-founders Racho Jordanov and Rose Lin pled guilty and were convicted of conspiring to steal trade secrets related to Genentech’s cystic fibrosis drug Pulmozyme, and cancer drugs Rituxan, Herceptin, and Avastin.  Although Jordanov and Lin initially pled not guilty, the former JHL employees later admitted to hiring former Genentech employees and using those employees’ knowledge of Genentech’s confidential information to advance JHL’s own biosimilar program.  Related to their conviction for trade secret theft, they also admitted to defrauding Sanofi, by misrepresenting the origins of JHL’s biosimilar product data.  Sentencing is scheduled for December 7, 2021.